about
Lung function in asbestos-exposed workers, a systematic review and meta-analysisMining the acute respiratory distress syndrome proteome: identification of the insulin-like growth factor (IGF)/IGF-binding protein-3 pathway in acute lung injuryPleural tuberculosis in patients with early HIV infection is associated with increased TNF-alpha expression and necrosis in granulomasAlveolar epithelium: beyond the barrier.Innovative approaches to the therapy of fibrosisAngiotensin-II-induced apoptosis requires regulation of nucleolin and Bcl-xL by SHP-2 in primary lung endothelial cells.Caveolin-1 deficiency may predispose African Americans to systemic sclerosis-related interstitial lung diseaseRepetitive intratracheal bleomycin models several features of idiopathic pulmonary fibrosis.Drug induced interstitial lung disease.Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycinDiscoidin domain receptor 1 contributes to the survival of lung fibroblast in idiopathic pulmonary fibrosisDisorders of lung matrix remodeling.Caveolin-1 signaling in lung fibrosis.Angiotensin II regulates activation of Bim via Rb/E2F1 during apoptosis: involvement of interaction between AMPKβ1/2 and Cdk4.Invasive breast cancer induces laminin-332 upregulation and integrin β4 neoexpression in myofibroblasts to confer an anoikis-resistant phenotype during tissue remodeling.Angiotensin-(1-7)/mas inhibits apoptosis in alveolar epithelial cells through upregulation of MAP kinase phosphatase-2.Genetic ablation of caveolin-2 sensitizes mice to bleomycin-induced injury.Racial differences between blacks and whites with systemic sclerosisComparison of bleomycin-induced pulmonary apoptosis between NMRI mice and C57BL/6 mice.Mouse Lung Fibroblast Resistance to Fas-Mediated Apoptosis Is Dependent on the Baculoviral Inhibitor of Apoptosis Protein 4 and the Cellular FLICE-Inhibitory Protein.Hepatocyte growth factor in lung repair and pulmonary fibrosis.Myofibroblast differentiation and survival in fibrotic disease.Cytochrome P450 polymorphisms and drug-induced interstitial lung disease.Hepatocyte growth factor is an attractive target for the treatment of pulmonary fibrosis.Susceptibility of Hermansky-Pudlak mice to bleomycin-induced type II cell apoptosis and fibrosis.Inhibition of ARC promoting the apoptosis of rat pulmonary arterial smooth muscle cells after serum deprivation in vitro.Insulin-like growth factor-I receptor blockade improves outcome in mouse model of lung injury.Potential contribution of alveolar epithelial type I cells to pulmonary fibrosis.Caveolin-1 and Caveolin-2 Can Be Antagonistic Partners in Inflammation and Beyond.NFATc3 pathway participates in the process that 15-LO/15-HETE protects pulmonary artery smooth muscle cells against apoptosis during hypoxia.Deterioration of alveolar development in mice with both HIF-3α knockout and HIF-2α knockdown.
P2860
Q28391439-11AB5DBC-8EF6-4BFC-AAF8-F96E4600A6EBQ30478475-9E2E194E-2DA8-4986-AF52-DBC388DFB1F3Q33401262-015D885F-6CC3-4657-9D3A-33AC86CFAE15Q33799762-3BD42C3A-85EC-4C63-A544-B6A7D9C6B965Q33824140-8F95C154-CFF5-40B5-B7C8-EC61C7F8AA4BQ33830299-4DCD7104-3C35-4032-AB14-AB97E4AA85D9Q34154288-D4E1FD04-88FA-4426-8B77-57E6A3A81FE1Q34212686-1D5C532A-BC6A-4F57-94DE-8D6063382957Q34641494-650F8396-3AA9-45B9-968E-7DC51DD63EF3Q35085416-EE2F8EA3-38C1-405B-80A5-DC079DCAA3B1Q35088066-BC5C4B28-2E2E-46EB-9F2C-5B2ED06C3969Q35628568-109D1F5C-F21A-48CE-9F9A-1C55BE710B8BQ36093857-108D15A4-0271-4950-A610-B66CD2C97AE8Q36178191-82E50D24-0C85-4D47-8571-337F63F41832Q36245413-8D4001F7-2BEF-4FCE-BA77-CF5FFA27E2F1Q36955317-350ACBB2-C8A5-44A4-B9BD-69CFFF2716A2Q37126182-80969EB3-5592-4544-864E-B7F33B46B13AQ37129649-39B3EA17-12C6-44FC-BB05-F0CDEE814833Q37491832-3DCE5EC5-127F-4729-8C53-1209D6B1BF0CQ37697394-9B4CAD8C-E19E-43D9-A2DB-25012ECB99BDQ37729853-18160444-5CF2-48C8-936D-8019D893A8F2Q37921386-C5ED1FBB-5002-4B71-890B-B9D3313E9484Q37954366-DB0F3A7C-7151-415A-9096-31A001749395Q38088776-9D81A500-032E-47F2-8531-46081722BE59Q42065927-771DA948-14BA-4157-AEB5-DD62065C87B3Q42679564-1FCD91E5-E953-4C21-818F-DBD5D9C9C3ADQ43191303-4E51AABA-223D-4651-AB93-86121F4213ADQ45888374-F8834CA8-AB60-4745-A58B-44E2716F89BAQ47138289-349461C4-09D1-452A-AF60-522401DCCA69Q51722031-0ECFB0FA-4E5B-42F7-8405-37EAB8FDAC31Q55609896-FD5206A7-6E84-40F3-B145-C0827EB4D914
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Apoptosis in lung fibrosis and repair.
@ast
Apoptosis in lung fibrosis and repair.
@en
type
label
Apoptosis in lung fibrosis and repair.
@ast
Apoptosis in lung fibrosis and repair.
@en
prefLabel
Apoptosis in lung fibrosis and repair.
@ast
Apoptosis in lung fibrosis and repair.
@en
P1433
P1476
Apoptosis in lung fibrosis and repair.
@en
P2093
Bruce D Uhal
P304
P356
10.1378/CHEST.122.6_SUPPL.293S
P407
P433
P577
2002-12-01T00:00:00Z